- Advocacy/Ethics
- Business of Medicine
Plenary III: From Vision to Value: Leading the Future of Neuromodulation
Details
- Date
- Saturday, January 23, 2027
- Time
- 8:30 AM – 10:00 AM
- Room
- Octavius Ballroom 4
- Session type
- Plenary
- Schedule
- See this day
About
As neuromodulation continues to expand across indications and care settings, ensuring its long-term impact requires more than scientific innovation alone. This plenary session explores the strategic, operational, and policy frameworks necessary to advance the field from promising therapies to sustainable standards of care. Faculty will examine the development of the first NANS clinical practice guidelines, discuss practical approaches to building financially viable neuromodulation programs, and explore how value-based care models can strengthen partnerships with payers by drawing lessons from other medical specialties. The session culminates with the NANS Presidential Address, highlighting our vision for the future of neuromodulation, followed by the Lifetime Achievement Address honoring an individual whose contributions have profoundly shaped the field.
Learning objectives
- Evaluate how NANS clinical guideline efforts, contributions to program infrastructure, and governance frameworks can standardize neuromodulation care delivery.
- Analyze practical strategies for building financially sustainable neuromodulation programs, including workforce planning, operational design, reimbursement optimization, and alignment with evolving healthcare system priorities.
- Discuss opportunities and barriers to implementing value-based neuromodulation models while supporting quality, safety, and scalability across diverse practice settings.
Faculty
-
-
Jeffrey S. Raskin, MD MS
Neurosurgeon
Northwestern University Feinberg School of Medicine · Chicago, Illinois
-
Ryan S. D'Souza, MD
Interventional Pain Physician, Professor, Director of Neuromodulation, Director of Research, Director of Anesthesia Clinical Research Unit
Mayo Clinic · Rochester, Minnesota
-
-
David A. Provenzano, MD
President of Pain Diagnostics and Interventional Care
Pain Diagnostics and Interventional Care · Sewickley, Pennsylvania
-
Hemant Kalia, MD
President & CEO
C.R.I.S.P Center for Research & Innovation in Spine & Pain · Rochester, New York
-
-
Magdalena Anitescu, MD, PhD
University of Chicago Medical Center · Chicago, Illinois
Presentations
-
Welcome
-
From Vision to Reality: Inside the Creation and Governance of the First NANS Guidelines
-
Making Neuromodulation Financially Viable: Business Models, Workforce Planning and Sustainable Program Design
-
Value-Based Neuromodulation: Is It Really Possible? Lessons From Oncology, Orthopedics, and Nephrology for Payer Contracting in Neuromodulation
-
Introduction of Presidential Address
-
Presidential Address
-
Introduction of Lifetime Achievement Award Recipient
-
Lifetime Achievement Award Presentation